Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Neurocrine Bioscience buy Raymond James

Start price
€105.50
01.11.23 / 50%
Target price
€137.63
01.11.24
Performance (%)
22.13%
Price
€128.85
30.04.24
Summary
This prediction is currently active. The BUY prediction by Raymond_James currently has a performance of 22.13%. This prediction currently runs until 01.11.24. The prediction end date can be changed by Raymond_James at any time. Raymond_James has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Neurocrine Bioscience -1.604% -1.604%
iShares Core DAX® -1.370% -3.231%
iShares Nasdaq 100 0.172% -3.339%
iShares Nikkei 225® -0.801% -7.859%
iShares S&P 500 -0.369% -2.979%

Comments by Raymond_James for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) 22.13%
Target price 137.634
Change
Ends at 01.11.24

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its price target raised by analysts at Raymond James from $135.00 to $145.00. They now have an "outperform" rating on the stock.
Ratings data for NBIX provided by MarketBeat